Evaluation Of Possible Antifibrotic Effect Of Cholecalciferol, Calci-Potriol, Aliskiren, Ramipril And Eprosartan On Carbon Tetrachloride Induced Liver Fibrosis In Albino Rats

Piceatannol supplementation: A promising therapeutic approach for Protection against Pulmonary Fibrosis

Potential Therapeutic Role of Osteopontin Inhibition in Liver Fibrosis -Induced by Thioacetamide in Rats

Heart Failure: Review on Pathophysiology and Pharmacological Therapy

Cardioprotective Effects of Nano-Vitamin D on Isoprenaline-Induced Myocardial Infarction Rat Model

Animal models of pulmonary hypertension; going beyond classical models of induction

Telmisartan inhibits the non-canonical TGF-β/JAK2/STAT3 signaling pathway and prevents carbon tetrachloride-induced liver fibrosis in rats

Overview of key molecular processes behind diabetic nephropathy

The beneficial Antifibrotic effect of Rosuvastatin on experimental Pulmonary Fibrosis induced by Bleomycin

Possible Protective Role of Pirfenidone Versus Combined Antifibrotic Therapy Colchicine and Pirfenidone in a Rat Model of Bleomycin Induced Pulmonary Fibrosis and Evaluation of t